NewAmsterdam Pharma (NAMS) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$19.93

+0.49 (+2.52%)

(As of 04/19/2024 ET)

Source

Source	Headline
	NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Up to $20.05 marketbeat.com - April 18 at 10:59 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Shares Up 2.6% marketbeat.com - April 16 at 1:40 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 2.1% marketbeat.com - April 10 at 2:51 PM
	BioAge Appoints Renowned Cardiologist and Biopharma Entrepreneur Michael H. Davidson, MD, to its Board of Directors businesswire.com - April 9 at 8:00 AM
	NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease globenewswire.com - April 9 at 8:00 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 4.9% marketbeat.com - April 8 at 11:59 AM
	Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and NewAmsterdam Pharma Company (NAMS) markets.businessinsider.com - April 2 at 8:25 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume marketbeat.com - April 1 at 2:01 PM
	NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer globenewswire.com - April 1 at 8:00 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Director Acquires $181,223.50 in Stock insidertrades.com - March 29 at 8:42 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $4,095,234.00 in Stock insidertrades.com - March 29 at 5:04 AM
	If you loved NBC's ER, this new Max medical drama is the show for you msn.com - March 28 at 8:17 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Director Buys $181,223.50 in Stock marketbeat.com - March 28 at 7:31 PM
	Johannes Jacob Piete Kastelein Sells 190,476 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock marketbeat.com - March 27 at 6:39 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Sees Strong Trading Volume marketbeat.com - March 26 at 12:36 PM
	NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress globenewswire.com - March 25 at 8:00 AM
	NAMS NewAmsterdam Pharma Company N.V. seekingalpha.com - March 19 at 10:02 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Recommendation of "Buy" by Analysts marketbeat.com - March 14 at 8:23 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Research Coverage Started at Scotiabank marketbeat.com - March 14 at 8:20 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 3.1% marketbeat.com - March 13 at 2:57 PM
	Amring Pharmaceuticals Rebrands as Nordic Pharma, Eyes Global Expansion with Strategic Acquisition msn.com - March 13 at 8:55 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Sees Large Volume Increase marketbeat.com - March 12 at 11:46 AM
	NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD globenewswire.com - March 12 at 8:00 AM
	NewAmsterdam Pharma Full Year 2023 Earnings: Revenues Miss Expectations finance.yahoo.com - March 1 at 9:45 AM
	Equities Analysts Set Expectations for NewAmsterdam Pharma's Q3 2025 Earnings (NASDAQ:NAMS) marketbeat.com - March 1 at 8:45 AM
	NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update finanznachrichten.de - February 28 at 11:24 AM
	NewAmsterdam Pharma Co NV (NAMS) Faces Net Loss in 2023 Despite Clinical Progress finance.yahoo.com - February 28 at 11:24 AM
	NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update globenewswire.com - February 28 at 8:00 AM
	Buy Rating Reaffirmed for NewAmsterdam Pharma with Increased Price Target Amid Promising Drug Trials and Strategic Initiatives markets.businessinsider.com - February 28 at 6:23 AM
	NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March finance.yahoo.com - February 26 at 2:49 PM
	NewAmsterdam Pharma Company N.V. (NAMS) Price Target Increased by 8.93% to 31.11 msn.com - February 24 at 1:50 AM
	NewAmsterdam Pharma Stock (NASDAQ:NAMS), Insider Trading Activity benzinga.com - February 23 at 8:49 PM
	List of Universities that offer pharmacy in South Africa in 2024 msn.com - February 20 at 12:38 AM
	NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants finanznachrichten.de - February 16 at 2:36 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Down to $20.00 marketbeat.com - February 14 at 12:01 PM
	NewAmsterdam Pharma prices $175M share offering seekingalpha.com - February 14 at 4:00 AM
	NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants finance.yahoo.com - February 14 at 3:13 AM
	NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants globenewswire.com - February 13 at 10:40 PM
	NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants finance.yahoo.com - February 13 at 5:11 PM
	Buy Rating on NewAmsterdam Pharma: Underappreciated Potential of Obicetrapib in CVD Market markets.businessinsider.com - February 13 at 12:10 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Shares Up 8.6% marketbeat.com - February 12 at 4:02 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Up to $19.57 marketbeat.com - February 9 at 1:32 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Shares Down 6.1% marketbeat.com - February 2 at 2:18 PM
	NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference finance.yahoo.com - February 1 at 7:13 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Short Interest Up 16.0% in January marketbeat.com - January 28 at 10:52 AM
	NewAmsterdam Pharma (NASDAQ:NAMS) Now Covered by Analysts at Guggenheim marketbeat.com - January 18 at 7:25 AM
	Cholesterol Player NewAmsterdam Pharma's Obicetrapib Is A Potential Blockbuster In Cardiovascular Market: Bullish Analyst Says msn.com - January 16 at 7:37 PM
	NewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated by Analysts at Piper Sandler marketbeat.com - January 16 at 9:08 AM
	NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors finance.yahoo.com - January 8 at 8:13 AM
	NewAmsterdam Pharma N.V.: NewAmsterdam Pharma Announces 2024 Strategic Priorities finanznachrichten.de - January 4 at 3:34 PM

Get NewAmsterdam Pharma News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

NAMS Media Mentions By Week

NAMS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NAMS
News Sentiment
▼
1.05

0.52
▲
Average
Medical
News Sentiment

NAMS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NAMS Articles
This Week
▼
2

1
▲
NAMS Articles
Average Week

Get NewAmsterdam Pharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:NAMS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NewAmsterdam Pharma (NAMS) News Today

NAMS Media Mentions By Week

NAMS Media Sentiment

NAMS News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info